STTK (shattucklabs.com) Sof foyda

STTK (shattucklabs.com) - kompaniyaning tovar belgisi

Shattuck Labs, Inc. (STTK) o'simtalarga qarshi kurashish uchun ARC platformasini ishlab chiqish orqali tartibga soluvchi o'zgarishlar xavfini yumshatmoqda. Kompaniyaning sof moliyaviy foydasi ushbu dinamikani aniq namoyish etadi, bunda -0.05 ko'rsatkichning bazaviy qiymatini aks ettiradi. AI algoritmlarining joriy etilishi dori vositalari sintezini optimallashtiradi, garchi shifokorlar nazoratni saqlab qolgan bo'lsa-da. Onkologiya muhitidagi nuqsonsiz imij brendning innovatsion proteinlarining yuqori qiymatini tasdiqlaydi.

STTK (Shattuck Labs, Inc.) Sof foyda tarixi 04.07.2022dan 30.10.2026gacha

shattucklabs.com (STTK) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Shattuck Labs|STTK - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi STTK|STTK - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Shattuck Labs|STTK - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi shattucklabs.com|STTK - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Shattuck Labs, Inc.|STTK - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Shattuck Labs|STTK - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar STTK|STTK - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Shattuck Labs|Shoshilinch likvidlik shattucklabs.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
STTK - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Shattuck Labs, Inc.
Shattuck Labs Inc asosiy tovari

Ushbu ko'rsatkich barcha operatsion va soliq xarajatlarini chegirib tashlagandan keyingi mablag'larning yakuniy sof balansini hisoblab, emitentning investitsiya ishonchliligini belgilaydi. Shattuck Labs, Inc. (STTK) kompaniyasining operatsion foydasini tahlil qilish orqali investor terapevtik proteinlar ishlab chiqish sohasidagi litsenziyalash shartnomalari va tadqiqot grantlarining monetizatsiya samaradorligini baholaydi, bu esa biznesning innovatsion saraton davolash usullaridan real daromad olish qobiliyatini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|upstreambio.com - Yakuniy foyda|ZBIO (Zenas Biopharma) - Sof foyda|Sof foyda Immunome Inc|Sof daromad GOSS (Gossamer Corp)|Soliqlar to‘langandan keyingi foyda KALV|Septerna Inc - Sof daromad|Soliqlar to‘langandan keyingi foyda PVLA (pieris.com)|SVRA: Sof daromad|RIGL - Sof foyda|ANAB: Sof foyda|Sof daromad Astria Corp|Kompaniyaning sof foydasi enGene Holdings Inc.|Sof foyda rapt.com|Sof daromad JBIO (Aerovate Therapeutics Inc)|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Kompaniyaning sof foydasi Kyverna KYTX|Tiziana Life Sciences, Ltd. - Kompaniyaning sof foydasi|Cabaletta Bio, Inc. - Sof foyda|VTYX - Sof foyda|THTX: Sof foyda|AVTX (Avalo Therapeutics, Inc.) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Eledon|Agenus, Inc (AGEN) - Sof moliyaviy natija|Sof daromad CLYM (Climb Bio Inc)|ZURA (zurabio.com) - Yakuniy foyda|Sof foyda ATYR (aTyr Pharma)|Sof moliyaviy natija Adagene Inc (ADAG)|IMA - Kompaniyaning sof foydasi|EQ (Equillium, Inc.) - Kompaniya foydasi|CNTB: Sof foyda|Sof daromad Immunic|Sof daromad ATRA|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Kompaniyaning sof foydasi X4 Pharma (XFOR)|Sof moliyaviy natija adicetbio.com|Celularity - Sof daromad|Soliqlar to‘langandan keyingi foyda INMB (inmunebio.com)|BRNS: Sof daromad|Kezar Life Sciences Inc. - Soliqlar to‘langandan keyingi foyda|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Akari Therapeutics, Plc (AKTX) - Sof foyda|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp - Soliqdan keyingi foyda|Sof foyda GOVX|EDSA (Edesa Biotech Inc) - Yakuniy foyda|Sof foyda IBIO (iBio Corp)|Sof foyda Carisma Therapeutics Inc CARM|XTLB - Kompaniyaning sof foydasi|Yakuniy foyda BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Sof daromad Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech) - Sof foyda|Sof foyda Aditxt Corp|Sof daromad GRI (GRI Bio, Inc.)|XRTX (xortx.com) - Yakuniy foyda|Sof foyda HIND (Vyome Holdings)|Sof moliyaviy natija Revelation Biosciences Inc (REVB)|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Sof daromad ALLK|Sof foyda HOOKIPA|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|iTeos Pharma - Kompaniya foydasi|Sof foyda OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com (TCBP) - Kompaniyaning sof daromadi|THRD - Kompaniyaning sof foydasi